SEC Form 4 · accession 0001415889-19-000168
CELGENE CORP /DE/ · CELG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ernest Mario
Director
Period of report
Feb 12, 2019
Accepted (ET)
Feb 14, 2019 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816284
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 14, 2019 | G | 5,100 | $0.00 | D | 57,913 | D | |
| Common StockF1,F2 | Feb 12, 2019 | P | 2,000 | $89.99 | A | 2,000 | I | Family Trust |
| Common StockF3 | holding | — | — | — | 324 | I | By Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were purchased by the reporting person in multiple transactions at prices ranging from $89.985 to $90.00, inclusive. The reporting person undertakes to provide Celgene Corporation (the "Company"), any security holder of the Company or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
- F2The reporting person disclaims beneficial ownership of these securities and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for the purpose of Section 16 or for any other purpose. These shares are held in the Ernest Mario 15-Year Residence Trustee, for which the reporting person is the trustee.
- F3The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.